Lupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million Market
Mumbai: Lupin Limited has announced the launch of Topiramate Extended-Release Capsules in the United States after receiving approval for its Abbreviated New Drug Application (ANDA) from the US Food and…